Keyphrases
Breast Cancer Research
100%
Industry-sponsored Clinical Trials
100%
Middle-income Countries
100%
Benefit Sharing
100%
Breast Cancer
44%
Low-income
44%
Innovative Therapies
33%
Phase II Trial
22%
Low-income Countries
22%
International Research
22%
Legal Framework
11%
Clinical Trials
11%
China
11%
Turkey
11%
I to
11%
Egypt
11%
Number of Trials
11%
World Bank
11%
Phase I Trial
11%
Blood Cancer
11%
Low-middle Income Countries
11%
Brazil
11%
India
11%
Lack of Access
11%
Interventional Study
11%
Ukraine
11%
Geographic Distribution
11%
Cancer Burden
11%
Cancer Clinical Trials
11%
Globalized
11%
Philippines
11%
Phase IV Trial
11%
Mexico
11%
Russian Federation
11%
Upper-middle Income Countries
11%
Pakistan
11%
Clinical Site
11%
Affordable Medicines
11%
Search Filter
11%
Access to Therapy
11%
Universal Access
11%
Anticancer Medicines
11%
Advanced Search
11%
Access to Cancer Care
11%
Rare Blood
11%
3-phase
11%
Medicine and Dentistry
Breast Cancer
100%
Medicine
100%
Clinical Trial
100%
Cancer Research
100%
Malignant Neoplasm
60%
Disease
20%
Health Care Cost
20%
Phase II Trials
20%
Phase I Trials
20%
Hematological Cancer
20%
Geographic Distribution
20%
Biochemistry, Genetics and Molecular Biology
Clinical Trial
100%
Geographic Distribution
33%
Phase II Trials
33%
Minimum Inhibitory Concentration
33%
Phase I Trials
33%
Agricultural and Biological Sciences
Minimum Inhibitory Concentration
100%